September 29, 2026 MILAN — Tirzepatide (Mounjaro, Eli Lilly) improved markers of beta-cell function and insulin sensitivity in people with
Miriam E. Tucker is a Writer/Journalist at various health-focused platforms. She specializes in medicine and healthcare, with a particular focus on endocrinology and immunology, and has a personal connection to her work as a long-time type 1 diabetes patient. Miriam's insights and expertise have been featured in The diaTribe Foundation, Knowledia, Medscape, Guidelines Co, MDEdge, and WebMD.